Recordati

Italian pharmaceutical company

ISIN IT0003828271 LEI 815600FBF92FD3531704
Follow Recordati Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2025 EUR · IFRS
EPS, diluted -
Revenue by fiscal year
€1.4B
€1.6B
FY20 FY21

Source: ESEF annual reports · latest filing